Advancing science is in our DNA
From the Human Genome Project to today’s quest for precision medicine, we’ve long invested in providing genomic products that reduce complexity and improve productivity. Our reagent portfolio is powered by Solid Phase Reversible Immobilization (SPRI) technology, widely known for use in our Agencourt AMPure XP, which uses paramagnetic beads to selectively bind nucleic acids by type and size. SPRI enables our chemistries to deliver high-performance isolation, purification and clean-up protocols supporting applications such as qPCR, Sanger sequencing, next-generation sequencing (NGS) and microarrays.
Our chemistries can be used interchangeably between manual methods and automated methods on Biomek liquid handlers, combining optimum performance with unprecedented flexibility.